TreeWAS – Variant ID: rs11158609

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
J84.1 Other interstitial pulmonary diseases with fibrosis	0.021	0.979	0.000
K51 Ulcerative colitis	0.000	0.981	0.019
K51.9 Ulcerative colitis, unspecified	0.000	0.981	0.019
K51.4 Pseudopolyposis of colon	0.000	0.982	0.018
K51.8 Other ulcerative colitis	0.000	0.982	0.018
K51.5 Mucosal proctocolitis	0.000	0.983	0.017
K51.3 Ulcerative (chronic) rectosigmoiditis	0.000	0.985	0.015
K51.0 Ulcerative (chronic) enterocolitis	0.000	0.987	0.013
K51.1 Ulcerative (chronic) ileocolitis	0.000	0.987	0.012
J84 Other interstitial pulmonary diseases	0.013	0.987	0.000
K51.2 Ulcerative (chronic) proctitis	0.000	0.988	0.012
J84.8 Other specified interstitial pulmonary diseases	0.011	0.989	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.990	0.009
J84.0 Alveolar and parietoalveolar conditions	0.009	0.991	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.991	0.009
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.991	0.009
J84.9 Interstitial pulmonary disease, unspecified	0.009	0.991	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.991	0.009
T45.0 Antiallergic and antiemetic drugs	0.000	0.991	0.009
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.991	0.009
D86.0 Sarcoidosis of lung	0.000	0.991	0.009
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.992	0.008
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.992	0.008
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.992	0.008
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.992	0.008
F06.7 Mild cognitive disorder	0.008	0.992	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.992	0.008
J32.0 Chronic maxillary sinusitis	0.000	0.992	0.008
D86 Sarcoidosis	0.000	0.992	0.008
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.992	0.008
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.992	0.008
T46.1 Calcium-channel blockers	0.000	0.992	0.008
T36 Poisoning by systemic antibiotics	0.000	0.992	0.008
T45.5 Anticoagulants	0.000	0.993	0.007
D86.8 Sarcoidosis of other and combined sites	0.000	0.993	0.007
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.993	0.007
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.993	0.007
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.993	0.007
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.993	0.007
T43.2 Other and unspecified antidepressants	0.000	0.993	0.007
D86.1 Sarcoidosis of lymph nodes	0.000	0.993	0.007
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.993	0.007
T46.7 Peripheral vasodilators	0.000	0.993	0.007
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.993	0.007
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.993	0.007
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.993	0.007
T36.0 Penicillins	0.000	0.993	0.007
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.993	0.007
T45.2 Vitamins, not elsewhere classified	0.000	0.993	0.007
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.993	0.007
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.993	0.007
T45.4 Iron and its compounds	0.000	0.993	0.007
T40.6 Other and unspecified narcotics	0.000	0.993	0.007
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.993	0.007
T45.8 Other primarily systemic and haematological agents	0.000	0.993	0.007
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.993	0.007
T45.6 Fibrinolysis-affecting drugs	0.000	0.993	0.007
T45.3 Enzymes, not elsewhere classified	0.000	0.993	0.007
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.993	0.007
F03 Unspecified dementia	0.000	0.993	0.007
S82.80 Fractures of other parts of lower leg (closed)	0.007	0.993	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.993	0.007
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.993	0.007
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.993	0.006
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.993	0.006
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.993	0.007
T39.4 Antirheumatics, not elsewhere classified	0.000	0.994	0.006
T39.2 Pyrazolone derivatives	0.000	0.994	0.006
T47.6 Antidiarrhoeal drugs	0.000	0.994	0.006
D86.3 Sarcoidosis of skin	0.000	0.994	0.006
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.994	0.006
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.994	0.006
D86.9 Sarcoidosis, unspecified	0.000	0.994	0.006
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.000	0.994	0.006
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.994	0.006
M70.65 Trochanteric bursitis-Pelvic/Thigh	0.006	0.994	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.994	0.006
T43.6 Psychostimulants with abuse potential	0.000	0.994	0.006
T47.4 Other laxatives	0.000	0.994	0.006
T36.3 Macrolides	0.000	0.994	0.006
T42.0 Hydantoin derivatives	0.000	0.994	0.006
T40.5 Cocaine	0.000	0.994	0.006
T43.9 Psychotropic drug, unspecified	0.000	0.994	0.006
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.994	0.006
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.994	0.006
T47.7 Emetics	0.000	0.994	0.006
T47.5 Digestants	0.000	0.994	0.006
T47.3 Saline and osmotic laxatives	0.000	0.994	0.006
T36.9 Systemic antibiotic, unspecified	0.000	0.994	0.006
T36.7 Antifungal antibiotics, systemically used	0.000	0.994	0.006
T36.6 Rifamycins	0.000	0.994	0.006
T36.5 Aminoglycosides	0.000	0.994	0.006
T36.2 Chloramphenicol group	0.000	0.994	0.006
T36.4 Tetracyclines	0.000	0.994	0.006
F00.9 Dementia in Alzheimer's disease, unspecified	0.000	0.994	0.006
A04.8 Other specified bacterial intestinal infections	0.000	0.994	0.006
T36.8 Other systemic antibiotics	0.000	0.994	0.005
T48.5 Anti-common-cold drugs	0.000	0.994	0.005
T47.0 Histamine H(2)-receptor antagonists	0.000	0.994	0.005
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.994	0.005
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.994	0.005
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.994	0.005
T40.1 Heroin	0.000	0.994	0.005
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.995	0.005
T40.8 Lysergide [LSD]	0.000	0.995	0.005
T40.7 Cannabis (derivatives)	0.000	0.995	0.005
T40.0 Opium	0.000	0.995	0.005
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.995	0.005
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.995	0.005
T42.2 Succinimides and oxazolidinediones	0.000	0.995	0.005
T50.4 Drugs affecting uric acid metabolism	0.000	0.995	0.005
T40.3 Methadone	0.000	0.995	0.005
T47.2 Stimulant laxatives	0.000	0.995	0.005
T41.2 Other and unspecified general anaesthetics	0.000	0.995	0.005
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.995	0.005
T48.4 Expectorants	0.000	0.995	0.005
T48.3 Antitussives	0.000	0.995	0.005
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.995	0.005
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.995	0.005
T48.0 Oxytocic drugs	0.000	0.995	0.005
F06 Other mental disorders due to brain damage and dysfunction and to physical disease	0.004	0.995	0.001
H54.9 Unspecified visual impairment (binocular)	0.005	0.995	0.000
T41.5 Therapeutic gases	0.000	0.995	0.005
T41.4 Anaesthetic, unspecified	0.000	0.995	0.005
T41.3 Local anaesthetics	0.000	0.995	0.005
T41.1 Intravenous anaesthetics	0.000	0.995	0.005
T41.0 Inhaled anaesthetics	0.000	0.995	0.005
T42.3 Barbiturates	0.000	0.995	0.005
T49.9 Topical agent, unspecified	0.000	0.995	0.005
T49.8 Other topical agents	0.000	0.995	0.005
T49.7 Dental drugs, topically applied	0.000	0.995	0.005
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.995	0.005
T49.5 Ophthalmological drugs and preparations	0.000	0.995	0.005
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.995	0.005
T49.3 Emollients, demulcents and protectants	0.000	0.995	0.005
T49.2 Local astringents and local detergents	0.000	0.995	0.005
T49.1 Antipruritics	0.000	0.995	0.005
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.995	0.005
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.995	0.005
T37.5 Antiviral drugs	0.000	0.995	0.005
T37.4 Anthelminthics	0.000	0.995	0.005
T37.3 Other antiprotozoal drugs	0.000	0.995	0.005
T37.1 Antimycobacterial drugs	0.000	0.995	0.005
T37.0 Sulphonamides	0.000	0.995	0.005
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.995	0.005
T50.7 Analeptics and opioid receptor antagonists	0.000	0.995	0.005
T50.5 Appetite depressants	0.000	0.995	0.005
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.995	0.005
T50.0 Mineralocorticoids and their antagonists	0.000	0.995	0.005
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.995	0.005
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.995	0.005
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.995	0.005
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.995	0.005
T50.8 Diagnostic agents	0.000	0.995	0.005
T50.1 Loop [high-ceiling] diuretics	0.000	0.995	0.005
T39.0 Salicylates	0.000	0.995	0.005
T42.1 Iminostilbenes	0.000	0.995	0.005
T38.9 Other and unspecified hormone antagonists	0.000	0.995	0.004
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.995	0.004
T38.7 Androgens and anabolic congeners	0.000	0.995	0.004
T38.5 Other oestrogens and progestogens	0.000	0.995	0.004
T38.4 Oral contraceptives	0.000	0.995	0.004
T38.2 Antithyroid drugs	0.000	0.995	0.004
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.995	0.005
T38.0 Glucocorticoids and synthetic analogues	0.000	0.995	0.004
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.995	0.005
H54.7 Unspecified visual loss	0.005	0.995	0.000
F00 Dementia in Alzheimer's disease	0.000	0.995	0.005
H54 Blindness and low vision	0.005	0.995	0.000
T40.2 Other opioids	0.000	0.995	0.005
M22.8 Other disorders of patella	0.000	0.995	0.005
N60.1 Diffuse cystic mastopathy	0.000	0.995	0.005
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.996	0.004
Y42.5 Other oestrogens and progestogens	0.000	0.996	0.004
T38.1 Thyroid hormones and substitutes	0.000	0.996	0.004
F06.2 Organic delusional [schizophrenia-like] disorder	0.003	0.996	0.001
F06.9 Unspecified mental disorder due to brain damage and dysfunction and to physical disease	0.003	0.996	0.001
F06.6 Organic emotionally labile [asthenic] disorder	0.003	0.996	0.001
F06.5 Organic dissociative disorder	0.003	0.996	0.001
F06.4 Organic anxiety disorder	0.003	0.996	0.001
F06.1 Organic catatonic disorder	0.003	0.996	0.001
F06.0 Organic hallucinosis	0.003	0.996	0.001
H54.1 Blindness, one eye, low vision, other eye	0.004	0.996	0.000
F06.3 Organic mood [affective] disorders	0.003	0.996	0.001
F06.8 Other specified mental disorders due to brain damage and dysfunction and to physical disease	0.003	0.996	0.001
M70.6 Trochanteric bursitis	0.004	0.996	0.000
F00-F09 Organic, including symptomatic, mental disorders	0.000	0.996	0.004
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.996	0.004
F00.2 Dementia in Alzheimer's disease, atypical or mixed type	0.000	0.996	0.004
H54.4 Blindness, one eye	0.004	0.996	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.996	0.004
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.996	0.004
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.996	0.004
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.996	0.004
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.996	0.004
T44.0 Anticholinesterase agents	0.000	0.996	0.004
H54.2 Low vision, both eyes	0.004	0.996	0.000
H54.3 Unqualified visual loss, both eyes	0.004	0.996	0.000
H54.6 Unqualified visual loss, one eye	0.004	0.996	0.000
S82.8 Fractures of other parts of lower leg	0.004	0.996	0.000
T42.4 Benzodiazepines	0.000	0.996	0.004
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.996	0.003
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.996	0.003
I84.2 Internal haemorrhoids without complication	0.004	0.996	0.000
T40.4 Other synthetic narcotics	0.000	0.996	0.003
F00.0 Dementia in Alzheimer's disease with early onset	0.000	0.997	0.003
T24.0 Burn of unspecified degree of hip and lower limb, except ankle and foot	0.000	0.997	0.003
F05 Delirium, not induced by alcohol and other psychoactive substances	0.000	0.997	0.003
C67.6 Ureteric orifice	0.003	0.997	0.000
F09 Unspecified organic or symptomatic mental disorder	0.000	0.997	0.003
H54.5 Low vision, one eye	0.003	0.997	0.000
M70.69 Trochanteric bursitis-Site unspec	0.003	0.997	0.000
F00.1 Dementia in Alzheimer's disease with late onset	0.000	0.997	0.003
S82.40 Fracture of fibula alone (closed)	0.003	0.997	0.000
J18.1 Lobar pneumonia, unspecified	0.000	0.997	0.003
F05.8 Other delirium	0.000	0.997	0.003
H54.0 Blindness, both eyes	0.003	0.997	0.000
M70.68 Trochanteric bursitis-Other	0.003	0.997	0.000
M70.67 Trochanteric bursitis-Ankle/Foot	0.003	0.997	0.000
M70.66 Trochanteric bursitis-Lower Leg	0.003	0.997	0.000
M70.64 Trochanteric bursitis-Hand	0.003	0.997	0.000
M70.63 Trochanteric bursitis-Forearm	0.003	0.997	0.000
M70.62 Trochanteric bursitis-Upper arm	0.003	0.997	0.000
M70.61 Trochanteric bursitis-Shldr region	0.003	0.997	0.000
M70.60 Trochanteric bursitis-Mult sites	0.003	0.997	0.000
T24.2 Burn of second degree of hip and lower limb, except ankle and foot	0.000	0.997	0.003
T24 Burn and corrosion of hip and lower limb, except ankle and foot	0.000	0.997	0.003
F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances	0.000	0.997	0.003
D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency	0.003	0.997	0.000
S82.00 Fracture of patella (closed)	0.003	0.997	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.997	0.003
M96.0 Pseudarthrosis after fusion or arthrodesis	0.000	0.997	0.003
W25.9 Unspecified place	0.003	0.997	0.000
L40.5 Arthropathic psoriasis	0.000	0.997	0.003
S82.86 Maisonneuve's fracture	0.003	0.997	0.000
T85.5 Mechanical complication of gastro-intestinal prosthetic devices, implants and grafts	0.000	0.997	0.003
F07 Personality and behavioural disorders due to brain disease, damage and dysfunction	0.000	0.997	0.003
B02.9 Zoster without complication	0.003	0.997	0.000
T23.2 Burn of second degree of wrist and hand	0.000	0.997	0.003
F01 Vascular dementia	0.000	0.997	0.003
F05.1 Delirium superimposed on dementia	0.000	0.997	0.003
H10.9 Conjunctivitis, unspecified	0.000	0.997	0.003
F02 Dementia in other diseases classified elsewhere	0.000	0.997	0.002
J43.9 Emphysema, unspecified	0.003	0.997	0.000
G55.2 Nerve root and plexus compressions in spondylosis	0.003	0.997	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.002
C67.1 Dome of bladder	0.003	0.997	0.000
C67.3 Anterior wall of bladder	0.003	0.997	0.000
T21 Burn and corrosion of trunk	0.000	0.997	0.003
F05.0 Delirium not superimposed on dementia, so described	0.000	0.997	0.002
I46.0 Cardiac arrest with successful resuscitation	0.000	0.997	0.003
S82.4 Fracture of fibula alone	0.003	0.997	0.000
C67 Malignant neoplasm of bladder	0.003	0.997	0.000
T21.2 Burn of second degree of trunk	0.000	0.997	0.002
J80-J84 Other respiratory diseases principally affecting the interstitium	0.002	0.997	0.000
T24.7 Corrosion of third degree of hip and lower limb, except ankle and foot	0.000	0.997	0.002
T24.6 Corrosion of second degree of hip and lower limb, except ankle and foot	0.000	0.997	0.002
T24.5 Corrosion of first degree of hip and lower limb, except ankle and foot	0.000	0.997	0.002
T24.4 Corrosion of unspecified degree of hip and lower limb, except ankle and foot	0.000	0.997	0.002
T24.3 Burn of third degree of hip and lower limb, except ankle and foot	0.000	0.997	0.002
C20 Malignant neoplasm of rectum	0.003	0.997	0.000
H57.8 Other specified disorders of eye and adnexa	0.000	0.997	0.002
E10.3 With ophthalmic complications	0.002	0.998	0.000
G57.6 Lesion of plantar nerve	0.002	0.998	0.000
T20-T25 Burns and corrosions of external body surface, specified by site	0.000	0.998	0.002
F05.9 Delirium, unspecified	0.000	0.998	0.002
J33.0 Polyp of nasal cavity	0.002	0.998	0.000
S82.0 Fracture of patella	0.002	0.998	0.000
T24.1 Burn of first degree of hip and lower limb, except ankle and foot	0.000	0.998	0.002
C67.4 Posterior wall of bladder	0.002	0.998	0.000
T23 Burn and corrosion of wrist and hand	0.000	0.998	0.002
G44.2 Tension-type headache	0.002	0.998	0.000
L89.9 Decubitus ulcer and pressure area, unspecified	0.002	0.998	0.000
S82.81 Fractures of other parts of lower leg (open)	0.002	0.998	0.000
F01.1 Multi-infarct dementia	0.000	0.998	0.002
G57 Mononeuropathies of lower limb	0.002	0.998	0.000
C67.5 Bladder neck	0.002	0.998	0.000
F07.8 Other organic personality and behavioural disorders due to brain disease, damage and dysfunction	0.000	0.998	0.002
F07.1 Postencephalitic syndrome	0.000	0.998	0.002
D80-D89 Certain disorders involving the immune mechanism	0.000	0.998	0.002
T21.3 Burn of third degree of trunk	0.000	0.998	0.002
F07.2 Postconcussional syndrome	0.000	0.998	0.002
G57.3 Lesion of lateral popliteal nerve	0.002	0.998	0.000
F01.8 Other vascular dementia	0.000	0.998	0.002
F01.3 Mixed cortical and subcortical vascular dementia	0.000	0.998	0.002
F01.2 Subcortical vascular dementia	0.000	0.998	0.002
F01.0 Vascular dementia of acute onset	0.000	0.998	0.002
G57.8 Other mononeuropathies of lower limb	0.002	0.998	0.000
C67.0 Trigone of bladder	0.002	0.998	0.000
F02.4 Dementia in human immunodeficiency virus [HIV] disease	0.000	0.998	0.002
F02.2 Dementia in Huntington's disease	0.000	0.998	0.002
F02.1 Dementia in Creutzfeldt-Jakob disease	0.000	0.998	0.002
T21.1 Burn of first degree of trunk	0.000	0.998	0.002
D51.9 Vitamin B12 deficiency anaemia, unspecified	0.002	0.998	0.000
F07.0 Organic personality disorder	0.000	0.998	0.002
G57.0 Lesion of sciatic nerve	0.002	0.998	0.000
M79.09 Rheumatism, unspecified (Site unspecified)	0.002	0.998	0.000
F07.9 Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction	0.000	0.998	0.002
T21.7 Corrosion of third degree of trunk	0.000	0.998	0.002
T21.6 Corrosion of second degree of trunk	0.000	0.998	0.002
T21.5 Corrosion of first degree of trunk	0.000	0.998	0.002
T21.4 Corrosion of unspecified degree of trunk	0.000	0.998	0.002
T21.0 Burn of unspecified degree of trunk	0.000	0.998	0.002
A04 Other bacterial intestinal infections	0.000	0.998	0.002
S82.41 Fracture of fibula alone (open)	0.002	0.998	0.000
C67.7 Urachus	0.002	0.998	0.000
D51 Vitamin B12 deficiency anaemia	0.002	0.998	0.000
H71 Cholesteatoma of middle ear	0.002	0.998	0.000
C67.2 Lateral wall of bladder	0.002	0.998	0.000
F02.3 Dementia in Parkinson's disease	0.000	0.998	0.002
T22 Burn and corrosion of shoulder and upper limb, except wrist and hand	0.000	0.998	0.002
F02.8 Dementia in other specified diseases classified elsewhere	0.000	0.998	0.002
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.998	0.002
L40.9 Psoriasis, unspecified	0.000	0.998	0.002
T22.2 Burn of second degree of shoulder and upper limb, except wrist and hand	0.000	0.998	0.002
T25 Burn and corrosion of ankle and foot	0.000	0.998	0.002
T23.1 Burn of first degree of wrist and hand	0.000	0.998	0.002
M70 Soft tissue disorders related to use, overuse and pressure	0.002	0.998	0.000
F02.0 Dementia in Pick's disease	0.000	0.998	0.002
I89.0 Lymphoedema, not elsewhere classified	0.002	0.998	0.000
M96 Postprocedural musculoskeletal disorders, not elsewhere classified	0.000	0.998	0.002
S82 Fracture of lower leg, including ankle	0.002	0.998	0.000
G57.1 Meralgia paraesthetica	0.002	0.998	0.000
D84 Other immunodeficiencies	0.000	0.998	0.002
A04.9 Bacterial intestinal infection, unspecified	0.000	0.998	0.002
Y42.7 Androgens and anabolic congeners	0.000	0.998	0.002
J81 Pulmonary oedema	0.002	0.998	0.000
M70.2 Olecranon bursitis	0.002	0.998	0.000
T23.7 Corrosion of third degree of wrist and hand	0.000	0.998	0.002
T23.6 Corrosion of second degree of wrist and hand	0.000	0.998	0.002
T23.5 Corrosion of first degree of wrist and hand	0.000	0.998	0.002
T23.4 Corrosion of unspecified degree of wrist and hand	0.000	0.998	0.002
T20 Burn and corrosion of head and neck	0.000	0.998	0.002
G57.4 Lesion of medial popliteal nerve	0.002	0.998	0.000
G57.2 Lesion of femoral nerve	0.002	0.998	0.000
G57.9 Mononeuropathy of lower limb, unspecified	0.002	0.998	0.000
A04.5 Campylobacter enteritis	0.000	0.998	0.002
G57.5 Tarsal tunnel syndrome	0.002	0.998	0.000
D82 Immunodeficiency associated with other major defects	0.000	0.998	0.002
D81 Combined immunodeficiencies	0.000	0.998	0.002
M70.22 Olecranon bursitis-Upper arm	0.002	0.998	0.000
N84.2 Polyp of vagina	0.002	0.998	0.000
T25.2 Burn of second degree of ankle and foot	0.000	0.998	0.002
J82 Pulmonary eosinophilia, not elsewhere classified	0.002	0.998	0.000
S82.01 Fracture of patella (open)	0.002	0.998	0.000
D51.8 Other vitamin B12 deficiency anaemias	0.002	0.998	0.000
K83.0 Cholangitis	0.000	0.998	0.002
M96.9 Postprocedural musculoskeletal disorder, unspecified	0.000	0.998	0.002
Y42.4 Oral contraceptives	0.000	0.998	0.002
B02 Zoster [herpes zoster]	0.002	0.998	0.000
M25.86 Other specified joint disorders (Lower leg)	0.002	0.998	0.000
Y42.9 Other and unspecified hormone antagonists	0.000	0.998	0.002
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.000	0.998	0.002
W25 Contact with sharp glass	0.002	0.998	0.000
B02.2 Zoster with other nervous system involvement	0.002	0.998	0.000
T20.2 Burn of second degree of head and neck	0.000	0.998	0.002
A04.6 Enteritis due to Yersinia enterocolitica	0.000	0.998	0.002
A04.3 Enterohaemorrhagic Escherichia coli infection	0.000	0.998	0.002
A04.2 Enteroinvasive Escherichia coli infection	0.000	0.998	0.002
A04.1 Enterotoxigenic Escherichia coli infection	0.000	0.998	0.002
A04.0 Enteropathogenic Escherichia coli infection	0.000	0.998	0.002
C67.8 Overlapping lesion of bladder	0.002	0.998	0.000
Y42.1 Thyroid hormones and substitutes	0.000	0.998	0.002
L40 Psoriasis	0.000	0.998	0.002
D51.2 Transcobalamin II deficiency	0.002	0.998	0.000
D51.1 Vitamin B12 deficiency anaemia due to selective vitamin B12 malabsorption with proteinuria	0.002	0.998	0.000
D84.8 Other specified immunodeficiencies	0.000	0.998	0.002
T22.3 Burn of third degree of shoulder and upper limb, except wrist and hand	0.000	0.998	0.002
T23.3 Burn of third degree of wrist and hand	0.000	0.998	0.002
D51.3 Other dietary vitamin B12 deficiency anaemia	0.002	0.998	0.000
J98.4 Other disorders of lung	0.002	0.998	0.000
R22.1 Localised swelling, mass and lump, neck	0.002	0.998	0.000
T22.7 Corrosion of third degree of shoulder and upper limb, except wrist and hand	0.000	0.998	0.002
T22.6 Corrosion of second degree of shoulder and upper limb, except wrist and hand	0.000	0.998	0.002
T22.5 Corrosion of first degree of shoulder and upper limb, except wrist and hand	0.000	0.998	0.002
T22.4 Corrosion of unspecified degree of shoulder and upper limb, except wrist and hand	0.000	0.998	0.002
D84.1 Defects in the complement system	0.000	0.998	0.002
S30.8 Other superficial injuries of abdomen, lower back and pelvis	0.000	0.998	0.002
T20.3 Burn of third degree of head and neck	0.000	0.998	0.002
T25.7 Corrosion of third degree of ankle and foot	0.000	0.998	0.002
T25.6 Corrosion of second degree of ankle and foot	0.000	0.998	0.002
T25.5 Corrosion of first degree of ankle and foot	0.000	0.998	0.002
T25.4 Corrosion of unspecified degree of ankle and foot	0.000	0.998	0.002
T25.1 Burn of first degree of ankle and foot	0.000	0.998	0.002
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.998	0.002
D83 Common variable immunodeficiency	0.000	0.998	0.002
M70.23 Olecranon bursitis-Forearm	0.002	0.998	0.000
M70.9 Unspecified soft tissue disorder related to use, overuse and pressure	0.002	0.998	0.000
M70.8 Other soft tissue disorders related to use, overuse and pressure	0.002	0.998	0.000
M70.1 Bursitis of hand	0.002	0.998	0.000
M96.8 Other postprocedural musculoskeletal disorders	0.000	0.998	0.002
Q63.0 Accessory kidney	0.000	0.998	0.002
S82.9 Fracture of lower leg, part unspecified	0.002	0.998	0.000
D89.1 Cryoglobulinaemia	0.000	0.998	0.002
H57.1 Ocular pain	0.000	0.998	0.002
M70.3 Other bursitis of elbow	0.002	0.998	0.000
M96.6 Fracture of bone following insertion of orthopaedic implant, joint prosthesis or bone plate	0.000	0.998	0.002
M96.4 Postsurgical lordosis	0.000	0.998	0.002
M96.3 Postlaminectomy kyphosis	0.000	0.998	0.002
M96.2 Postradiation kyphosis	0.000	0.998	0.002
M96.1 Postlaminectomy syndrome, not elsewhere classified	0.000	0.998	0.002
Y42.2 Antithyroid drugs	0.000	0.998	0.002
D84.0 Lymphocyte function antigen-1 [LFA-1] defect	0.000	0.998	0.002
M70.5 Other bursitis of knee	0.002	0.998	0.000
M70.0 Chronic crepitant synovitis of hand and wrist	0.002	0.998	0.000
T25.0 Burn of unspecified degree of ankle and foot	0.000	0.998	0.001
M70.29 Olecranon bursitis-Site unspec	0.001	0.998	0.000
M70.28 Olecranon bursitis-Other	0.001	0.998	0.000
M70.27 Olecranon bursitis-Ankle/Foot	0.001	0.998	0.000
M70.26 Olecranon bursitis-Lower Leg	0.001	0.998	0.000
M70.25 Olecranon bursitis-Pelvic/Thigh	0.001	0.998	0.000
M70.24 Olecranon bursitis-Hand	0.001	0.998	0.000
M70.21 Olecranon bursitis-Shldr region	0.001	0.998	0.000
M70.20 Olecranon bursitis-Mult sites	0.001	0.998	0.000
E87.7 Fluid overload	0.000	0.998	0.002
D84.9 Immunodeficiency, unspecified	0.000	0.998	0.002
M70.7 Other bursitis of hip	0.002	0.998	0.000
S05.8 Other injuries of eye and orbit	0.000	0.998	0.002
T20.7 Corrosion of third degree of head and neck	0.000	0.998	0.001
T20.6 Corrosion of second degree of head and neck	0.000	0.998	0.001
T20.5 Corrosion of first degree of head and neck	0.000	0.998	0.001
T20.4 Corrosion of unspecified degree of head and neck	0.000	0.998	0.001
D89.9 Disorder involving the immune mechanism, unspecified	0.000	0.998	0.002
B02.1 Zoster meningitis	0.002	0.998	0.000
D81.9 Combined immunodeficiency, unspecified	0.000	0.998	0.001
D81.8 Other combined immunodeficiencies	0.000	0.998	0.001
D81.7 Major histocompatibility complex class II deficiency	0.000	0.998	0.001
D81.6 Major histocompatibility complex class I deficiency	0.000	0.998	0.001
D81.5 Purine nucleoside phosphorylase [PNP] deficiency	0.000	0.998	0.001
D81.4 Nezelof's syndrome	0.000	0.998	0.001
D81.3 Adenosine deaminase [ADA] deficiency	0.000	0.998	0.001
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers	0.000	0.998	0.001
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers	0.000	0.998	0.001
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis	0.000	0.998	0.001
D82.9 Immunodeficiency associated with major defect, unspecified	0.000	0.998	0.001
D82.8 Immunodeficiency associated with other specified major defects	0.000	0.998	0.001
D82.4 Hyperimmunoglobulin E [IgE] syndrome	0.000	0.998	0.001
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus	0.000	0.998	0.001
D82.2 Immunodeficiency with short-limbed stature	0.000	0.998	0.001
D82.0 Wiskott-Aldrich syndrome	0.000	0.998	0.001
L40.1 Generalised pustular psoriasis	0.000	0.998	0.002
M96.5 Postradiation scoliosis	0.000	0.998	0.001
T25.3 Burn of third degree of ankle and foot	0.000	0.998	0.001
Y42.0 Glucocorticoids and synthetic analogs	0.000	0.998	0.002
F01.9 Vascular dementia, unspecified	0.000	0.998	0.001
T22.1 Burn of first degree of shoulder and upper limb, except wrist and hand	0.000	0.998	0.001
T22.0 Burn of unspecified degree of shoulder and upper limb, except wrist and hand	0.000	0.998	0.001
H57 Other disorders of eye and adnexa	0.000	0.998	0.002
B02.3 Zoster ocular disease	0.002	0.998	0.000
D82.1 Di George's syndrome	0.000	0.998	0.001
B02.7 Disseminated zoster	0.001	0.998	0.000
B02.0 Zoster encephalitis	0.001	0.998	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.000	0.998	0.001
D37.4 Colon	0.002	0.998	0.000
D89.3 Immune reconstitution syndrome	0.000	0.998	0.001
D89.0 Polyclonal hypergammaglobulinaemia	0.000	0.998	0.001
H57.0 Anomalies of pupillary function	0.000	0.998	0.002
S82.7 Multiple fractures of lower leg	0.001	0.998	0.000
W25.6 Industrial and construction area	0.001	0.998	0.000
W25.5 Trade and service area	0.001	0.998	0.000
W25.1 Residential institution	0.001	0.998	0.000
W25.0 Home	0.001	0.998	0.000
W25.7 Farm	0.001	0.998	0.000
W25.4 Street and highway	0.001	0.998	0.000
W25.3 Sports and athletics area	0.001	0.998	0.000
M86.97 Osteomyelitis, unspecified (Ankle and foot)	0.002	0.998	0.000
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified	0.000	0.998	0.001
L40.2 Acrodermatitis continua	0.000	0.998	0.001
T23.0 Burn of unspecified degree of wrist and hand	0.000	0.998	0.001
A04.4 Other intestinal Escherichia coli infections	0.000	0.998	0.001
L40.3 Pustulosis palmaris et plantaris	0.000	0.998	0.001
S82.3 Fracture of lower end of tibia	0.001	0.998	0.000
T20.0 Burn of unspecified degree of head and neck	0.000	0.998	0.001
W22.5 Trade and service area	0.001	0.998	0.000
M86.98 Osteomyelitis, unspecified (Other)	0.001	0.998	0.000
S82.90 Fracture of lower leg, part unspecified (closed)	0.001	0.998	0.000
D83.8 Other common variable immunodeficiencies	0.000	0.998	0.001
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells	0.000	0.998	0.001
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders	0.000	0.998	0.001
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function	0.000	0.998	0.001
M22 Disorders of patella	0.000	0.998	0.002
R54 Senility	0.002	0.998	0.000
W22 Striking against or struck by other objects	0.002	0.998	0.000
M70.19 Bursitis of hand-Site unspec	0.001	0.998	0.000
M70.18 Bursitis of hand-Other	0.001	0.998	0.000
M70.17 Bursitis of hand-Ankle/Foot	0.001	0.998	0.000
M70.16 Bursitis of hand-Lower Leg	0.001	0.998	0.000
M70.15 Bursitis of hand-Pelvic/Thigh	0.001	0.998	0.000
M70.14 Bursitis of hand-Hand	0.001	0.998	0.000
M70.13 Bursitis of hand-Forearm	0.001	0.998	0.000
M70.12 Bursitis of hand-Upper arm	0.001	0.998	0.000
M70.11 Bursitis of hand-Shldr region	0.001	0.998	0.000
M70.10 Bursitis of hand-Mult sites	0.001	0.998	0.000
M70.89 Other soft tissue disorders related to use, overuse and pressure (Site unspecified)	0.001	0.998	0.000
M70.88 Other soft tissue disorders related to use, overuse and pressure (Other)	0.001	0.998	0.000
M70.87 Other soft tissue disorders related to use, overuse and pressure (Ankle and foot)	0.001	0.998	0.000
M70.86 Other soft tissue disorders related to use, overuse and pressure (Lower leg)	0.001	0.998	0.000
M70.85 Other soft tissue disorders related to use, overuse and pressure (Pelvic region and thigh)	0.001	0.998	0.000
M70.84 Other soft tissue disorders related to use, overuse and pressure (Hand)	0.001	0.998	0.000
M70.83 Other soft tissue disorders related to use, overuse and pressure (Forearm)	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations